₹329 to ₹346 per equity share of face value of ₹2. Blue Jet Healthcare IPO has reserved not more than 50% of the shares in the public issue for Qualified Institutional Buyers (QIB), not less than 15% for Non Institutional Investors (NII), and not less than 35% of the offer is reserved for Retail Investors. On day 1, Blue Jet IPO retail investors portion was subscribed 78%, NII portion was subscribed 1.37 times, and Qualified Institutional Buyers (QIB) portion were booked just by 1%.
Also Read: Blue Jet Healthcare IPO: 10 key risks investors should know before subscribing to the issue Blue Jet Healthcare IPO has received bids for 1,16,53,645 shares against 1,69,99,612 shares on offer, according to data from the BSE. Blue Jet IPO retail investors' portion received bids for 66,33,137 shares against 84,99,806 shares on offer for this segment. Also Read: Blue Jet Healthcare IPO: Blue Jet IPO raises ₹252.08 crore from anchor investors; details here Blue Jet Healthcare IPO's non-institutional investors' portion received bids for 49,83,657 shares against 36,42,774 on offer for this segment.
Blue Jet IPO Qualified Institutional Buyers (QIBs) portion received bids for 36,851 shares against 48,57,032 shares on offer for this segment. Blue Jet Healthcare IPO is completely a offer for sale (OFS) of 24,285,160 equity share; there is no fresh issue component, according to Red Herring Prospectus (RHP). Blue Jet Healthcare IPO size is ₹840.27 crore.
The company's promoters are Shiven Akshay Arora, Akshay Bansarilal Arora, and Archana & Akshay Arora. Also Read: Blue Jet Healthcare IPO: GMP, subscription status, review, other details. Apply or not? Shiven Akshay Arora will sell up to 5,918,849 equity shares, while Akshay Bansarilal Arora
. Read more on livemint.com